vs

Side-by-side financial comparison of HEALTHCARE SERVICES GROUP INC (HCSG) and INNOSPEC INC. (IOSP). Click either name above to swap in a different company.

HEALTHCARE SERVICES GROUP INC is the larger business by last-quarter revenue ($466.7M vs $455.6M, roughly 1.0× INNOSPEC INC.). On growth, HEALTHCARE SERVICES GROUP INC posted the faster year-over-year revenue change (6.6% vs -2.4%). INNOSPEC INC. produced more free cash flow last quarter ($46.8M vs $16.0M). Over the past eight quarters, HEALTHCARE SERVICES GROUP INC's revenue compounded faster (5.0% CAGR vs -4.6%).

Tenet Healthcare Corporation is an American for-profit multinational healthcare services company based in Dallas. Through its brands, subsidiaries, joint ventures, and partnerships including United Surgical Partners International (USPI), the company operates 65 hospitals and over 450 healthcare facilities. Tenet also runs Conifer Health Solutions, which provides healthcare support services to health systems and other clients.

Innospec Inc., formerly known as Octel Corporation and Associated Octel Company, Ltd., is an American specialty chemical company. It comprises three business units:The Performance Chemicals business trades in the personal care, home care, agrochemical, mining and industrial markets. The Fuel Specialties business specializes in manufacturing and supplying fuel additives. The Oilfield Services business supplies drilling, completion and production chemicals.

HCSG vs IOSP — Head-to-Head

Bigger by revenue
HCSG
HCSG
1.0× larger
HCSG
$466.7M
$455.6M
IOSP
Growing faster (revenue YoY)
HCSG
HCSG
+9.0% gap
HCSG
6.6%
-2.4%
IOSP
More free cash flow
IOSP
IOSP
$30.8M more FCF
IOSP
$46.8M
$16.0M
HCSG
Faster 2-yr revenue CAGR
HCSG
HCSG
Annualised
HCSG
5.0%
-4.6%
IOSP

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
HCSG
HCSG
IOSP
IOSP
Revenue
$466.7M
$455.6M
Net Profit
$47.4M
Gross Margin
15.4%
28.0%
Operating Margin
6.1%
10.3%
Net Margin
10.4%
Revenue YoY
6.6%
-2.4%
Net Profit YoY
167.3%
EPS (diluted)
$0.43
$1.90

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
HCSG
HCSG
IOSP
IOSP
Q4 25
$466.7M
$455.6M
Q3 25
$464.3M
$441.9M
Q2 25
$458.5M
$439.7M
Q1 25
$447.7M
$440.8M
Q4 24
$437.8M
$466.8M
Q3 24
$428.1M
$443.4M
Q2 24
$426.3M
$435.0M
Q1 24
$423.4M
$500.2M
Net Profit
HCSG
HCSG
IOSP
IOSP
Q4 25
$47.4M
Q3 25
$43.0M
$12.9M
Q2 25
$-32.4M
$23.5M
Q1 25
$17.2M
$32.8M
Q4 24
$-70.4M
Q3 24
$14.0M
$33.4M
Q2 24
$-1.8M
$31.2M
Q1 24
$15.3M
$41.4M
Gross Margin
HCSG
HCSG
IOSP
IOSP
Q4 25
15.4%
28.0%
Q3 25
20.8%
26.4%
Q2 25
0.6%
28.0%
Q1 25
15.2%
28.4%
Q4 24
13.4%
29.2%
Q3 24
14.8%
28.0%
Q2 24
9.7%
29.2%
Q1 24
15.2%
31.1%
Operating Margin
HCSG
HCSG
IOSP
IOSP
Q4 25
6.1%
10.3%
Q3 25
12.3%
1.3%
Q2 25
-9.1%
7.8%
Q1 25
5.3%
9.6%
Q4 24
3.4%
8.8%
Q3 24
4.4%
10.3%
Q2 24
-0.5%
9.4%
Q1 24
5.0%
10.1%
Net Margin
HCSG
HCSG
IOSP
IOSP
Q4 25
10.4%
Q3 25
9.3%
2.9%
Q2 25
-7.1%
5.3%
Q1 25
3.8%
7.4%
Q4 24
-15.1%
Q3 24
3.3%
7.5%
Q2 24
-0.4%
7.2%
Q1 24
3.6%
8.3%
EPS (diluted)
HCSG
HCSG
IOSP
IOSP
Q4 25
$0.43
$1.90
Q3 25
$0.59
$0.52
Q2 25
$-0.44
$0.94
Q1 25
$0.23
$1.31
Q4 24
$0.15
$-2.80
Q3 24
$0.19
$1.33
Q2 24
$-0.02
$1.24
Q1 24
$0.21
$1.65

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
HCSG
HCSG
IOSP
IOSP
Cash + ST InvestmentsLiquidity on hand
$168.0M
$292.5M
Total DebtLower is stronger
Stockholders' EquityBook value
$510.2M
$1.3B
Total Assets
$794.3M
$1.8B
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
HCSG
HCSG
IOSP
IOSP
Q4 25
$168.0M
$292.5M
Q3 25
$177.5M
$270.8M
Q2 25
$134.5M
$266.6M
Q1 25
$114.8M
$299.8M
Q4 24
$107.3M
$289.2M
Q3 24
$103.8M
$303.8M
Q2 24
$105.6M
$240.2M
Q1 24
$104.9M
$270.1M
Stockholders' Equity
HCSG
HCSG
IOSP
IOSP
Q4 25
$510.2M
$1.3B
Q3 25
$496.0M
$1.3B
Q2 25
$477.0M
$1.3B
Q1 25
$514.2M
$1.3B
Q4 24
$499.9M
$1.2B
Q3 24
$488.7M
$1.2B
Q2 24
$471.4M
$1.2B
Q1 24
$474.6M
$1.2B
Total Assets
HCSG
HCSG
IOSP
IOSP
Q4 25
$794.3M
$1.8B
Q3 25
$804.3M
$1.8B
Q2 25
$802.2M
$1.8B
Q1 25
$823.0M
$1.8B
Q4 24
$802.8M
$1.7B
Q3 24
$805.8M
$1.8B
Q2 24
$799.7M
$1.7B
Q1 24
$803.9M
$1.7B

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
HCSG
HCSG
IOSP
IOSP
Operating Cash FlowLast quarter
$17.4M
$61.4M
Free Cash FlowOCF − Capex
$16.0M
$46.8M
FCF MarginFCF / Revenue
3.4%
10.3%
Capex IntensityCapex / Revenue
0.3%
3.2%
Cash ConversionOCF / Net Profit
1.30×
TTM Free Cash FlowTrailing 4 quarters
$139.2M
$88.0M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
HCSG
HCSG
IOSP
IOSP
Q4 25
$17.4M
$61.4M
Q3 25
$71.3M
$39.3M
Q2 25
$28.8M
$9.3M
Q1 25
$27.5M
$28.3M
Q4 24
$36.2M
$25.7M
Q3 24
$4.3M
$73.5M
Q2 24
$16.3M
$4.7M
Q1 24
$-26.0M
$80.6M
Free Cash Flow
HCSG
HCSG
IOSP
IOSP
Q4 25
$16.0M
$46.8M
Q3 25
$70.0M
$25.0M
Q2 25
$27.4M
$-3.7M
Q1 25
$25.8M
$19.9M
Q4 24
$34.8M
$13.6M
Q3 24
$2.9M
$65.8M
Q2 24
$15.0M
$-6.2M
Q1 24
$-28.2M
$69.9M
FCF Margin
HCSG
HCSG
IOSP
IOSP
Q4 25
3.4%
10.3%
Q3 25
15.1%
5.7%
Q2 25
6.0%
-0.8%
Q1 25
5.8%
4.5%
Q4 24
7.9%
2.9%
Q3 24
0.7%
14.8%
Q2 24
3.5%
-1.4%
Q1 24
-6.7%
14.0%
Capex Intensity
HCSG
HCSG
IOSP
IOSP
Q4 25
0.3%
3.2%
Q3 25
0.3%
3.2%
Q2 25
0.3%
3.0%
Q1 25
0.4%
1.9%
Q4 24
0.3%
2.6%
Q3 24
0.3%
1.7%
Q2 24
0.3%
2.5%
Q1 24
0.5%
2.1%
Cash Conversion
HCSG
HCSG
IOSP
IOSP
Q4 25
1.30×
Q3 25
1.66×
3.05×
Q2 25
0.40×
Q1 25
1.60×
0.86×
Q4 24
Q3 24
0.31×
2.20×
Q2 24
0.15×
Q1 24
-1.70×
1.95×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

HCSG
HCSG

Dietary Services$255.9M55%
Other$210.8M45%

IOSP
IOSP

Refinery And Performance$147.0M32%
Personal Care$99.7M22%
Oilfield Services$93.1M20%
Other Fuel Specialties$47.1M10%
Other Performance Chemicals$40.0M9%
Home Care$28.7M6%

Related Comparisons